Checkpoint Therapeutics Stock
Price
Target price
-
-
-
-
-
?4.42
WKN: A2JAHK / Symbol: CKPT / Name: Checkpoint Therapeutics / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Checkpoint Therapeutics Stock
With 0 Sell predictions and 2 Buy predictions the community sentiment towards the Checkpoint Therapeutics stock is not clear.
Based on the current price of 0.5 € the target price of 4 € shows a potential of 698.08% for Checkpoint Therapeutics which would more than double the current price.
Pros and Cons of Checkpoint Therapeutics in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Checkpoint Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Checkpoint Therapeutics | - | - | - | - | - | - | - |
| Biocryst Pharmaceuticals | -0.690% | 10.691% | 11.041% | -29.256% | -3.661% | -33.530% | -33.600% |
| Heron Therapeutics Inc. | 0.970% | 4.317% | -16.530% | -37.844% | -8.887% | -58.673% | -93.265% |
| Madrigal Pharmaceuticals inc. | -2.070% | -5.401% | -14.246% | 10.725% | -25.858% | 30.141% | 265.760% |
Comments
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $4.80 price target on the stock.
Show more
Ratings data for CKPT provided by MarketBeat
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $4.80 price target on the stock.
Show more
Ratings data for CKPT provided by MarketBeat
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) is now covered by analysts at D. Boral Capital. They set a "buy" rating and a $9.00 price target on the stock.
Show more
Ratings data for CKPT provided by MarketBeat